Invention Grant
- Patent Title: Pyrrolidine GPR40 modulators for the treatment of diseases such as diabetes
-
Application No.: US15308428Application Date: 2015-05-06
-
Publication No.: US10017497B2Publication Date: 2018-07-10
- Inventor: Chongqing Sun
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Yong Lu; Barry H. Jacobsen
- International Application: PCT/US2015/029422 WO 20150506
- International Announcement: WO2015/171733 WO 20151112
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/497 ; A61K45/06
Abstract:
The present invention provides compounds of Formula (I) or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.
Public/Granted literature
- US20170217930A1 PYRROLIDINE GPR40 MODULATORS FOR THE TREATMENT OF DISEASES SUCH AS DIABETES Public/Granted day:2017-08-03
Information query
